THE FREQUENCY OF EGFR AND KRAS MUTATIONS IN NON-SMALL CELL LUNG CARCINOMAS IN THE DUTCH POPULATION

被引：0
|
作者：
Smits, Alexander J. J. [1 ]
Kummer, J. A. [1 ]
Hinrichs, John [2 ]
Herder, Gerarda J. M. [1 ]
Jiwa, N. M. [3 ]
Ruijters, T. E. G. [4 ]
Nooijen, P. T. G. A. [5 ]
Looijen-salamon, Monika G. [6 ]
Ligtenberg, M. J. [6 ]
Thunnissen, Frederik B. [7 ]
Heideman, Danielle A. [7 ]
De Weger, R. A. [2 ]
Vink, Aryan [2 ]
机构：
[1] St Antonius Hosp, Nieuwegein, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Med Ctr Alkmaar, Alkmaar, Netherlands
[4] Alysis Zorggrp Arnhem, Arnhem, Netherlands
[5] Jeroen Bosch Hosp Hertogenbosch, sHertogenbosch, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[7] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
lung carcinoma; EGFR mutation; KRAS mutation; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1528 / S1528
页数：1
相关论文
共 50 条
  • [41] Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations
    Wells, Leah
    Qin, Angel
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1978 - 1993
  • [42] Impact of EGFR mutations on treatment of non-small cell lung cancer
    Bruce E. Johnson
    David Jackman
    Pasi A. Jänne
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 5 - 9
  • [43] Impact of EGFR mutations on treatment of non-small cell lung cancer
    Johnson, Bruce E.
    Jackman, David
    Janne, Pasi A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (Suppl 1) : S5 - S9
  • [44] DETECTING EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hammoudeh, Z. A.
    Antonova, O.
    Staneva, R.
    Nikolova, D.
    Kyuchukov, Y.
    Penev, A.
    Mintchev, T.
    Koleva, V
    Hadjidekova, S.
    Toncheva, D.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2018, 21 (01) : 13 - 17
  • [45] EGFR mutations in non-small cell lung carcinomas may predict response to gefitinib - Extension of an emerging paradigm
    Chang, KL
    Lau, SK
    ADVANCES IN ANATOMIC PATHOLOGY, 2005, 12 (02) : 47 - 52
  • [46] Yield of EGFR and ALKTesting in Poorly Differentiated Non-Small Cell Lung Carcinomas
    Allen, Charles
    Yang, Bin
    Farver, Carol
    Mukhopadhyay, Sanjay
    MODERN PATHOLOGY, 2015, 28 : 471A - 471A
  • [47] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] KRAS Mutations as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer
    Martin, Petra
    Leighl, Natasha B.
    Tsao, Ming-Sound
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (05) : 530 - 542
  • [49] KRAS codon 12 mutations in Australian non-small cell lung cancer
    Fong, KM
    Zimmerman, PV
    Smith, PJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (02): : 184 - 189
  • [50] EGFR and KRAS Mutations and Disease Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy
    Liu, Y.
    Xu, T.
    Pang, Q.
    Zhuang, Y.
    Tsao, A.
    Lu, C.
    Komaki, R. U.
    Liao, Z.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E435 - E436
12345